Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Interdisciplinary Toxicology
Volume 3 (2010): Issue 2 (June 2010)
Open Access
DNA and histone deacetylases as targets for neuroblastoma treatment
Marie Stiborová
Marie Stiborová
,
Jitka Poljaková
Jitka Poljaková
,
Tomáš Eckschlager
Tomáš Eckschlager
,
Rene Kizek
Rene Kizek
and
Eva Frei
Eva Frei
| Jul 30, 2010
Interdisciplinary Toxicology
Volume 3 (2010): Issue 2 (June 2010)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jul 30, 2010
Page range:
47 - 52
DOI:
https://doi.org/10.2478/v10102-010-0010-6
Keywords
neuroblastoma
,
DNA-damaging anticancer drugs
,
inhibitors of histone deacetylases
,
mechanisms of acticancer effects of drugs
This content is open access.
Marie Stiborová
Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
Jitka Poljaková
Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
Tomáš Eckschlager
Department of Pediatric Hematology and Oncology, 2nd Medical School, Charles University and University Hospital Motol, Prague, Czech Republic
Rene Kizek
Department of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University of Agriculture and Forestry, Brno, Czech Republic
Eva Frei
Division of Preventive Oncology, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany